Clinical pharmacology study of ipragliflozin in Japanese patients with type 1 diabetes mellitus: A phase 2, randomized, placebo‐controlled trial

AIM: To evaluate the pharmacodynamics, pharmacokinetics, and safety of the novel oral sodium‐glucose co‐transporter‐2 inhibitor, ipragliflozin, in Japanese patients with type 1 diabetes mellitus. MATERIALS AND METHODS: We conducted a multicentre, double‐blind, placebo‐controlled, parallel‐group stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaku, Kohei, Isaka, Hiroyuki, Toyoshima, Junko, Sakatani, Taishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594083/
https://www.ncbi.nlm.nih.gov/pubmed/30821047
http://dx.doi.org/10.1111/dom.13679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594083/
https://www.ncbi.nlm.nih.gov/pubmed/30821047
http://dx.doi.org/10.1111/dom.13679

Ejemplares similares